Literature DB >> 23967673

[Gastric ulcer and duodenal ulcer].

Masaki Miyamoto1, Ken Haruma.   

Abstract

Peptic ulcer diseases are improved by strong acid suppression therapy. However, peptic ulcer diseases are often relapsed after discontinuing of acid suppression therapy. After discovery of Helicobacter pylori (H. pylori) in 1984, H. pylori is known as the strongest causal agent for peptic ulcer diseases. In November 2000, eradication therapy for H. pylori infection was approved under the Japanese system of health insurance. H. pylori eradication reduces ulcer recurrence dramatically. Recently, peptic ulcer diseases induced by NSAIDs and/or aspirin are increasing. In prevention of NSAIDs and/or aspirin induced peptic ulcer recurrence, H. pylori eradication plus PPI treatment is recommended. Several reports described occurrence of newly-developed gastric cancer after H. pylori eradication. Careful follow-up upper gastrointestinal endoscopy is necessary after H. pylori eradication.

Entities:  

Mesh:

Year:  2013        PMID: 23967673

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  The Metabonomic Studies of Tongue Coating in H. pylori Positive Chronic Gastritis Patients.

Authors:  Xuan Liu; Zhu-Mei Sun; Yan-Na Liu; Qing Ji; Hua Sui; Li-Hong Zhou; Fu-Feng Li; Qi Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

2.  Metachronous early gastric cancer over a period of 13 years after eradication of Helicobacter pylori.

Authors:  Atsushi Mitsunaga; Tomoko Tagata; Tetsuya Hamano; Honami Teramoto; Motoyasu Kan; Yutaka Mitsunaga; Maki Tobari; Izumi Shirato; Miho Shirato; Shuhei Yoshida; Masahiko Shimada; Takayoshi Nishino
Journal:  Clin J Gastroenterol       Date:  2014-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.